R&D
Results, reality, and recalibration: Unpacking AI hype at SC...
SCOPE 2026 was dominated by one big topic: AI. You couldn’t walk five steps without hearing about something that AI was going to fix.
Digital
AI scientists and the robotic labs of tomorrow
AI scientists will no longer operate at the margins of life sciences research - they'll become essential collaborators in the labs of tomorrow.
Oncology
Daiichi Sankyo gears up for five ADC launches in 2026
On the sidelines of JPM, Daiichi-Sankyo US CEO Ken Keller told pharmaphorum about the company's big year and its long-term strategy in ADCs.
Digital
On digital health and the Rural Health Transformation Progra...
As reported in January this year, the United States Centers for Medicare & Medicaid Services (CMS) rolled out $10 billion in
R&D
Why the government’s latest funding push is critical to the ...
Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
